Lantern Pharma Inc.
LTRN · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Schalop Lee Troy: Form 4
Insider disclosure · Filed · Report period 12 May 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 10-K/A
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- LTRN · 51654W101 - Common Stock, $0.0001 par value per share
Company details and SEC sources
CIK 0001763950 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- LTRN on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 1920 Mckinney Avenue, 7 Th Floor, Dallas, TX, 75201
- Incorporated in
- TX
- Fiscal year end
- 31 December
- Former names on EDGAR
- Lantern Pharma (to 14 Jan 2019)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields